New York State Common Retirement Fund Ikena Oncology, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.24 - $1.82 $18,239 - $26,770	-14,709 Reduced 98.11%	283 $0
Q4 2023 Feb 01, 2024	SELL	$1.33 - $4.4 $93 - $308	-70 Reduced 0.46%	14,992 $30,000
Q3 2023 Nov 07, 2023	BUY	$4.09 - $6.43 $1,071 - $1,684	262 Added 1.77%	15,062 $65,000
Q2 2023 Aug 07, 2023	BUY	$3.5 - $7.31 $51,800 - $108,188	14,800 New	14,800 $97,000
Q2 2022 Aug 04, 2022	SELL	$3.23 - $7.4 $70,623 - $161,801	-21,865 Reduced 99.09%	201 $1,000
Q1 2022 May 05, 2022	BUY	$5.61 - $13.85 $47,023 - $116,090	8,382 Added 61.25%	22,066 $135,000
Q4 2021 Feb 02, 2022	BUY	$10.52 - $16.96 $62,015 - $99,979	5,895 Added 75.68%	13,684 $172,000
Q3 2021 Nov 02, 2021	BUY	$9.82 - $15.23 $873 - $1,355	89 Added 1.16%	7,789 $98,000
Q2 2021 Aug 02, 2021	BUY	$13.27 - $26.0 $102,179 - $200,200	7,700 New	7,700 $108,000

30.6M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $61.3M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.